Read more
Placebo Effects in Neurologic Disease, Volume 153, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on Background and Methods in Placebo, Better than Nothing: A Historical Account of Placebos and Placebo Effects from Modern to Contemporary Medicine, Determinants of PE, Strategies for Minimizing PE in Research, Maximizing placebo response in the clinic, Statistical methods for handling PE, Nocebo and Lessebo effects, Ethics of deception, Pain, Parkinson's Disease, Cognitive impairment, Epilepsy, and much more.
List of contents
Part 1: Background and methods in placebo
- Better than nothing: A historical account of placebos and placebo effects from modern to contemporary medicine
Marco Annoni
- Determinants of placebo effects
Sharlet Anderson and Glenn T. Stebbins
- Strategies to minimize placebo effects in research investigations
Filipe B Rodrigues and Joaquim J Ferreira
- Maximizing placebo response in neurological clinical practice
Louise-Laure Mariani and Jean-Christophe Corvol
- Statistical methods in handling placebo effect
Rema Raman
- Nocebo and lessebo effects
Tiago A. Mestre
- Deception and the ethics of placebo
A. Jon Stoessl
Part 2: Placebo response in specific disease populations
- Placebo effects in pain
Luana Colloca
- Placebo responses in Parkinson's disease
Jau-Shin Lou
- Placebo effect in subjects with cognitive impairment
Kaori Ito and Klaus Romero
- Placebo in epilepsy
Daniel M. Goldenholz and Shira R. Goldenholz
About the author
Natalie Witek is at Rush Parkinson’s Disease and Movement Disorders Program, USAProfessor and Associate Chairman, Department of Neurological Sciences, Rush University, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL
Professor of Neurological ScienceGlenn Stebbins is at Rush Parkinson’s Disease and Movement Disorders Program, USA
